3/26
01:03 am
ophly
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan [Yahoo! Finance]
Neutral
Report
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan [Yahoo! Finance]
3/5
08:22 pm
ophly
Ono Pharmaceutical (TSE:4528) Valuation Check As New Neurology And Rare Disease Partnerships Advance [Yahoo! Finance]
Low
Report
Ono Pharmaceutical (TSE:4528) Valuation Check As New Neurology And Rare Disease Partnerships Advance [Yahoo! Finance]
3/3
08:23 am
ophly
Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders [Yahoo! Finance]
Low
Report
Sinopia Biosciences Announces Target Discovery Collaboration with Ono Pharmaceutical for Rare Metabolic Disorders [Yahoo! Finance]
3/2
08:21 pm
ophly
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology [Yahoo! Finance]
Low
Report
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology [Yahoo! Finance]
3/2
05:13 pm
ophly
Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs [Yahoo! Finance]
Low
Report
Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs [Yahoo! Finance]
2/2
01:23 am
ophly
Ono Pharmaceutical GAAP EPS of ¥146.07, revenue of ¥397.04B; reaffirms FY outlook [Seeking Alpha]
Medium
Report
Ono Pharmaceutical GAAP EPS of ¥146.07, revenue of ¥397.04B; reaffirms FY outlook [Seeking Alpha]